Product Information
ANAGRELIDE HCL 0.5 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.7295 per EA under NDC 70954087910. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application on Apr 18, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954087910
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ANAGRELIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076811FDA Approved
4/18/2005
TE Code
AB
On Market Since
11/6/2025
Pharmacological Classes
Price Statistics
The NADAC for ANAGRELIDE HCL 0.5 MG CAPSULE has been published 42 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7295 per EA |
|---|---|
| All-time high | $0.7345 (Sep 16, 2026) |
| All-time low | $0.7214 (May 20, 2026) |
| 52-week high | $0.7345 |
| 52-week low | $0.7214 |
| Median price | $0.7265 |
| Average price | $0.7277 |
| Largest weekly change | +0.8% (Feb 18, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Anagrelide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Platelet-reducing Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANAGRELIDE HCL 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ANAGRELIDE HCL 0.5 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $0.7295 per EA (NDC 70954087910), effective Sep 30, 2026.
How has the price of ANAGRELIDE HCL 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ANAGRELIDE HCL 0.5 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for ANAGRELIDE HCL 0.5 MG CAPSULE?
Since Dec 17, 2025, the NADAC for ANAGRELIDE HCL 0.5 MG CAPSULE has ranged from a low of $0.7214 (May 20, 2026) to a high of $0.7345 (Sep 16, 2026), with a median of $0.7265 per EA.
Are there cheaper alternatives to ANAGRELIDE HCL 0.5 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ANAGRELIDE HCL 0.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ANAGRELIDE HCL 0.5 MG CAPSULE?
ANAGRELIDE HCL 0.5 MG CAPSULE (NDC 70954087910) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.